View More View Less
  • 1 Semmelweis University Institute of Medical Microbiology Budapest Hungary
  • | 2 Semmelweis University Department of Pharmaceutics Budapest Hungary
  • | 3 Semmelweis University Department of Laboratory Medicine Budapest Hungary
  • | 4 Semmelweis University Department of Orthopedics Budapest Hungary
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

Biofilm-forming Staphylococcus epidermidis strains are common cause of the periprosthetic infection. The treatment of the periprosthetic infection is very problematic, so the prevention of these infections by an antibiotic containing prothesis could be an option for prevention.The purpose of the present study was to examine the in vitro effects of drug delivery systems (DDSs), namely Wax 1 and Wax 2 with different vancomycin content: 0.5, 1, 2 and 4 mg. In order to control the antibacterial activity of DDSs killing curve study was performed and in order to determine the antibiotic release and the antibiotic peak concentration from the DDSs biological assay was carried out.The time kill curve studies showed, that both DDSs with all vancomycin concentration decreased significantly the bacterial counts, however, Wax 2 with 4 mg vancomycin significantly decreased the bacterial count than all the other groups.The vancomycin release was the best with the highest peak concentration from DDSs with 4 mg vancomycin contain; it was significantly better than in the other groups, however, no significant difference was observed between Wax 1 and Wax 2 in this respect.These findings suggest that Wax 2 with 4 mg vancomycin content could be a potential agent for clinical use.

  • Winkler, H., Kaudela, K., Stoiber, A., Menschik, F.: Bone grafts impregnated with antibiotics as a tool for treating infected implants in orthopedic surgery — one stage revision results. Cell Tissue Banking 7, 319–323 (2006).

    Menschik F. , 'Bone grafts impregnated with antibiotics as a tool for treating infected implants in orthopedic surgery — one stage revision results ' (2006 ) 7 Cell Tissue Banking : 319 -323.

    • Search Google Scholar
  • Antoci, V. Jr., Adams, C.S., Parvizi, J., Davidson, H.M., Composto, R.J., Freeman, T.A., Wickstrom, E., Ducheyne, P., Jungkind, D., Shapiro, I.M., Hickok, N.J.: The inhibition of Staphylococcus epidermidis biofilm formation by vancomycin-modified titanium alloy and implications for the treatment of periprosthetic infection. Biomaterials 29, 4684–4690 (2008).

    Hickok N.J. , 'The inhibition of Staphylococcus epidermidis biofilm formation by vancomycin-modified titanium alloy and implications for the treatment of periprosthetic infection ' (2008 ) 29 Biomaterials : 4684 -4690.

    • Search Google Scholar
  • Witso, E., Persen, L., Løseth, K., Benum, P., Bergh, K.: Cancellous bone as an antibiotic carrier. Acta Orthop Scand 71, 80–84 (2000).

    Bergh K. , 'Cancellous bone as an antibiotic carrier ' (2000 ) 71 Acta Orthop Scand : 80 -84.

  • Chen, C.E., Ko, J.Y., Pan, C.C.: Result of vancomycin impregnated cancellous bone grafting for infected tibial nonunion. Arch Orthop Trauma Surg 125, 369–375 (2005).

    Pan C.C. , 'Result of vancomycin impregnated cancellous bone grafting for infected tibial nonunion ' (2005 ) 125 Arch Orthop Trauma Surg : 369 -375.

    • Search Google Scholar
  • Buttaro, M.A., Pusso, R., Piccaluga, F.: Vancomycin-supplemented impacted bone allografts in infected hip arthroplasty. Two-stage revision results. J Bone Joint Surg Br 87, 314–319 (2005).

    Piccaluga F. , 'Vancomycin-supplemented impacted bone allografts in infected hip arthroplasty. Two-stage revision results ' (2005 ) 87 J Bone Joint Surg Br : 314 -319.

    • Search Google Scholar
  • Buttaro, M.A., Comba, F., Pusso, R., Piccaluga, F.: Acetabular revision with metal mesh, impaction bone grafting, and a cemented cup. Clin Orthop Relat Res 466, 2482–2490 (2008).

    Piccaluga F. , 'Acetabular revision with metal mesh, impaction bone grafting, and a cemented cup ' (2008 ) 466 Clin Orthop Relat Res : 2482 -2490.

    • Search Google Scholar
  • Winkler, H., Janata, O., Berger, C., Wein, W., Georgopoulos, A.: In vitro release of vancomycin and torbramycin from impregnated human and bovine grafts. J Antimicrob Chemother 46, 423–428 (2000).

    Georgopoulos A. , 'In vitro release of vancomycin and torbramycin from impregnated human and bovine grafts ' (2000 ) 46 J Antimicrob Chemother : 423 -428.

    • Search Google Scholar
  • Laki, M., Hajdú, M., Ludányi, K., Zahár, A., Szendrői, M., Klebovich, I., Antal, I.: Evaluation of a New LC Method for analysis of vancomycin released froman orthopaedic drug carrier system. Chromatographia 68, 141–144 (2008).

    Antal I. , 'Evaluation of a New LC Method for analysis of vancomycin released froman orthopaedic drug carrier system ' (2008 ) 68 Chromatographia : 141 -144.

    • Search Google Scholar
  • Laki, M.: Investigation of carries systems containing antibiotics used in bone surgery. PhD thesis. Semmelweis University. 2010.

    Laki M. , '', in Investigation of carries systems containing antibiotics used in bone surgery , (2010 ) -.

  • Mentec, H., Vallois, J., Bure, A., Saleh-Mghir, A., Jehl, F., Carbon, C.: Piperacillin, tazobactam, and gentamicin alone or combined in an endocarditis model of infection by a TEM-3-producing strain of Klebsiella pneumoniae or its susceptible variant. Antimicrob Agents Chemother 36, 1883–1889 (1992).

    Carbon C. , 'Piperacillin, tazobactam, and gentamicin alone or combined in an endocarditis model of infection by a TEM-3-producing strain of Klebsiella pneumoniae or its susceptible variant ' (1992 ) 36 Antimicrob Agents Chemother : 1883 -1889.

    • Search Google Scholar
  • Anhalt, J.P.: Assays for antimicrobial agents in body fluids. In: Lennette, E.H., Balows, A., Hausler, W.J. Jr., Shadomy, H.J. (eds), Manual of Clinical Microbiology, 4th ed. American Society for Microbiology, Washington, D.C., 1985, pp. 1009–1014.

    Anhalt J.P. , '', in Manual of Clinical Microbiology , (1985 ) -.

  • Valour, F., Trouillet-Assant, S., Rasigade, J.P., Lustig, S., Chanard, E., Meugnier, H., Tigaud, S., Vandenesch, F., Etienne, J., Ferry, T., Laurent, F., Lyon BJI Study Group. Staphylococcus epidermidis in orthopedic device infections: the role of bacterial internalization in human osteoblasts and biofilm formation. PLoS One 8, e67240 (2013).

    Laurent F. , 'Staphylococcus epidermidis in orthopedic device infections: the role of bacterial internalization in human osteoblasts and biofilm formation ' (2013 ) 8 PLoS One : e67240 -.

    • Search Google Scholar
  • Hellmark, B., Söderquist, B., Unemo, M., Nilsdotter-Augustinsson, Å.: Comparison of Staphylococcus epidermidis isolated from prosthetic joint infections and commensal isolates in regard to antibiotic susceptibility, agr type, biofilm production, and epidemiology. Int J Med Microbiol. 303, 32–39 (2013).

    Nilsdotter-Augustinsson Å. , 'Comparison of Staphylococcus epidermidis isolated from prosthetic joint infections and commensal isolates in regard to antibiotic susceptibility, agr type, biofilm production, and epidemiology ' (2013 ) 303 Int J Med Microbiol. : 32 -39.

    • Search Google Scholar
  • Hellmark, B., Unemo, M., Nilsdotter-Augustinsson, A., Söderquist, B.: Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections with special focus on rifampicin and variability of the rpoB gene. ClinMicrobiol Infect 15, 238–244 (2009).

    Söderquist B. , 'Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections with special focus on rifampicin and variability of the rpoB gene ' (2009 ) 15 ClinMicrobiol Infect : 238 -244.

    • Search Google Scholar
  • Dunne, W.M., Jr, Mason, E.O., Jr, Kaplan, S.L.: Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm. Antimicrob Agents Chemother 37, 2522–2526 (1993).

    Kaplan S.L. , 'Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm ' (1993 ) 37 Antimicrob Agents Chemother : 2522 -2526.

    • Search Google Scholar
  • Laki, M., Hajdú, M., Zahár, A., Sáska, Z., Klebovich, I., Szendroi, M., Antal, I.: Designing antibiotic-containing carrier systems used in bone surgery. Acta Pharm Hung. 77, 108–115 (2007).

    Antal I. , 'Designing antibiotic-containing carrier systems used in bone surgery ' (2007 ) 77 Acta Pharm Hung. : 108 -115.

    • Search Google Scholar
  • Neut, D., Kluin, O.S., Thompson, J., van der Mei, H.C., Busscher, H.J.: Gentamicin release from commercially-available gentamicin-loaded PMMA bone cements in a prosthesis-related interfacial gapmodel and their antibacterial efficacy. BMC Musculoskeletal Disorders 11, 258 (2010).

    Busscher H.J. , 'Gentamicin release from commercially-available gentamicin-loaded PMMA bone cements in a prosthesis-related interfacial gapmodel and their antibacterial efficacy ' (2010 ) 11 BMC Musculoskeletal Disorders : 258 -.

    • Search Google Scholar
  • Rasyid, H.N., van der Mei, H.C., Frijlink, H.W., Soegijoko, S., van Horn, J.R., Busscher, H.J., Neut, D.: Concepts for increasing gentamicin release from handmade bone cement beads. Acta Orthop 80, 508–513 (2009).

    Neut D. , 'Concepts for increasing gentamicin release from handmade bone cement beads ' (2009 ) 80 Acta Orthop : 508 -513.

    • Search Google Scholar
  • Taggart, T., Kerry, R.M., Norman, P., Stockley, I.: The use of vancomycin-impregnated cement beads in the management of infection of prosthetic joints. J Bone Joint Surg Br. 84, 70–72 (2002).

    Stockley I. , 'The use of vancomycin-impregnated cement beads in the management of infection of prosthetic joints ' (2002 ) 84 J Bone Joint Surg Br. : 70 -72.

    • Search Google Scholar

 

The author instruction is available in PDF.
Please, download the file from HERE

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Zsuzsanna SCHAFF (2nd Department of Pathology, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded

2019  
Total Cites
WoS
485
Impact Factor 1,086
Impact Factor
without
Journal Self Cites
0,864
5 Year
Impact Factor
1,233
Immediacy
Index
0,286
Citable
Items
42
Total
Articles
40
Total
Reviews
2
Cited
Half-Life
5,8
Citing
Half-Life
7,7
Eigenfactor
Score
0,00059
Article Influence
Score
0,246
% Articles
in
Citable Items
95,24
Normalized
Eigenfactor
0,07317
Average
IF
Percentile
7,690
Scimago
H-index
27
Scimago
Journal Rank
0,352
Scopus
Scite Score
320/161=2
Scopus
Scite Score Rank
General Immunology and Microbiology 35/45 (Q4)
Scopus
SNIP
0,492
Acceptance
Rate
16%

 

Acta Microbiologica et Immunologica Hungarica
Publication Model Online only Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription Information Online subsscription: 652 EUR / 812 USD
Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Publication
Programme
2021 Volume 68
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Jan 2021 0 0 0
Feb 2021 5 0 0
Mar 2021 13 1 1
Apr 2021 8 0 0
May 2021 7 0 0
Jun 2021 0 0 0
Jul 2021 0 0 0